NAD+ Repletion Rescues Female Fertility during Reproductive Aging

DOI DOI HANDLE HANDLE Web Site ほか2件をすべて表示 一部だけ表示 被引用文献10件 オープンアクセス

書誌事項

公開日
2020-02
権利情報
  • https://www.elsevier.com/tdm/userlicense/1.0/
  • https://www.elsevier.com/legal/tdmrep-license
  • http://creativecommons.org/licenses/by-nc-nd/4.0/
DOI
  • 10.1016/j.celrep.2020.01.058
  • 10.34961/6658
公開者
Elsevier BV

この論文をさがす

説明

Reproductive aging in female mammals is an irreversible process associated with declining oocyte quality, which is the rate-limiting factor to fertility. Here, we show that this loss of oocyte quality with age accompanies declining levels of the prominent metabolic cofactor nicotinamide adenine dinucleotide (NAD+). Treatment with the NAD+ metabolic precursor nicotinamide mononucleotide (NMN) rejuvenates oocyte quality in aged animals, leading to restoration in fertility, and this can be recapitulated by transgenic overexpression of the NAD+-dependent deacylase SIRT2, though deletion of this enzyme does not impair oocyte quality. These benefits of NMN extend to the developing embryo, where supplementation reverses the adverse effect of maternal age on developmental milestones. These findings suggest that late-life restoration of NAD+ levels represents an opportunity to rescue female reproductive function in mammals.

peer-reviewed

収録刊行物

  • Cell Reports

    Cell Reports 30 (6), 1670-1681.e7, 2020-02

    Elsevier BV

被引用文献 (10)*注記

もっと見る

キーワード

問題の指摘

ページトップへ